The Nobel prize in medicine, this year, was given to Drs. Honjo and Allison. Dr. Honjo...
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
The Nobel prize in medicine, this year, was given to Drs. Honjo and Allison. Dr. Honjo discovered a protein called PD-1 on the cell membrane of T cells. When this protein (receptor) binds to its ligand: PD-IL (PD-1 ligand) which is found on Macrophages, the T cells stop growing/differentiating and therefore stop functioning. The reason Dr. Honjo was given the Nobel price is because he developed a monoclonal antibody (anti-PD-1) which blocks the interaction between PD-1 and its ligand PD-1L (the antibody is called Nivolumab). PD-1L can also be expressed by tumor cells. So if a T cell recognizes a tumor cell via its TCR, it will not kill it, if the tumor expresses PD-1L. Given this information please answer the questions given below: KD P1 P2 a. You want to give Nivolumab to two patients with skin cancer. Before you give the antibody, you obtain tumor tissue from both patients P1 and P2 and you perform a Western blotting experiment using their tumor tissues using anti-PD-1 antibody and obtain the results shown on the right (PD-1 is a 40kD molecule). For which of these two patients (P1 or P2?) would you expect Nivolumab to help the immune system fight cancer? Please explain your logic briefly. 70- A 50- 30- 15 10- 5- b. PD-1 is a receptor that binds a relay protein (RP) which is normally bound to the intracellular domain of the PD-1 molecule. When PD-1 binds to PD-IL, the relay protein dissociates from PD-1 and starts functioning as a transcription factor. The figure below is an IHC experiment using T cells that have been exposed to PD-1L; where the primary antibody is "anti-RP". Which cells have been treated with PD-IL and which cells represent "control", untreated cells? (A or B?). Please explain your logic briefly. B The Nobel prize in medicine, this year, was given to Drs. Honjo and Allison. Dr. Honjo discovered a protein called PD-1 on the cell membrane of T cells. When this protein (receptor) binds to its ligand: PD-IL (PD-1 ligand) which is found on Macrophages, the T cells stop growing/differentiating and therefore stop functioning. The reason Dr. Honjo was given the Nobel price is because he developed a monoclonal antibody (anti-PD-1) which blocks the interaction between PD-1 and its ligand PD-1L (the antibody is called Nivolumab). PD-1L can also be expressed by tumor cells. So if a T cell recognizes a tumor cell via its TCR, it will not kill it, if the tumor expresses PD-1L. Given this information please answer the questions given below: KD P1 P2 a. You want to give Nivolumab to two patients with skin cancer. Before you give the antibody, you obtain tumor tissue from both patients P1 and P2 and you perform a Western blotting experiment using their tumor tissues using anti-PD-1 antibody and obtain the results shown on the right (PD-1 is a 40kD molecule). For which of these two patients (P1 or P2?) would you expect Nivolumab to help the immune system fight cancer? Please explain your logic briefly. 70- A 50- 30- 15 10- 5- b. PD-1 is a receptor that binds a relay protein (RP) which is normally bound to the intracellular domain of the PD-1 molecule. When PD-1 binds to PD-IL, the relay protein dissociates from PD-1 and starts functioning as a transcription factor. The figure below is an IHC experiment using T cells that have been exposed to PD-1L; where the primary antibody is "anti-RP". Which cells have been treated with PD-IL and which cells represent "control", untreated cells? (A or B?). Please explain your logic briefly. B The Nobel prize in medicine, this year, was given to Drs. Honjo and Allison. Dr. Honjo discovered a protein called PD-1 on the cell membrane of T cells. When this protein (receptor) binds to its ligand: PD-IL (PD-1 ligand) which is found on Macrophages, the T cells stop growing/differentiating and therefore stop functioning. The reason Dr. Honjo was given the Nobel price is because he developed a monoclonal antibody (anti-PD-1) which blocks the interaction between PD-1 and its ligand PD-1L (the antibody is called Nivolumab). PD-1L can also be expressed by tumor cells. So if a T cell recognizes a tumor cell via its TCR, it will not kill it, if the tumor expresses PD-1L. Given this information please answer the questions given below: KD P1 P2 a. You want to give Nivolumab to two patients with skin cancer. Before you give the antibody, you obtain tumor tissue from both patients P1 and P2 and you perform a Western blotting experiment using their tumor tissues using anti-PD-1 antibody and obtain the results shown on the right (PD-1 is a 40kD molecule). For which of these two patients (P1 or P2?) would you expect Nivolumab to help the immune system fight cancer? Please explain your logic briefly. 70- A 50- 30- 15 10- 5- b. PD-1 is a receptor that binds a relay protein (RP) which is normally bound to the intracellular domain of the PD-1 molecule. When PD-1 binds to PD-IL, the relay protein dissociates from PD-1 and starts functioning as a transcription factor. The figure below is an IHC experiment using T cells that have been exposed to PD-1L; where the primary antibody is "anti-RP". Which cells have been treated with PD-IL and which cells represent "control", untreated cells? (A or B?). Please explain your logic briefly. B The Nobel prize in medicine, this year, was given to Drs. Honjo and Allison. Dr. Honjo discovered a protein called PD-1 on the cell membrane of T cells. When this protein (receptor) binds to its ligand: PD-IL (PD-1 ligand) which is found on Macrophages, the T cells stop growing/differentiating and therefore stop functioning. The reason Dr. Honjo was given the Nobel price is because he developed a monoclonal antibody (anti-PD-1) which blocks the interaction between PD-1 and its ligand PD-1L (the antibody is called Nivolumab). PD-1L can also be expressed by tumor cells. So if a T cell recognizes a tumor cell via its TCR, it will not kill it, if the tumor expresses PD-1L. Given this information please answer the questions given below: KD P1 P2 a. You want to give Nivolumab to two patients with skin cancer. Before you give the antibody, you obtain tumor tissue from both patients P1 and P2 and you perform a Western blotting experiment using their tumor tissues using anti-PD-1 antibody and obtain the results shown on the right (PD-1 is a 40kD molecule). For which of these two patients (P1 or P2?) would you expect Nivolumab to help the immune system fight cancer? Please explain your logic briefly. 70- A 50- 30- 15 10- 5- b. PD-1 is a receptor that binds a relay protein (RP) which is normally bound to the intracellular domain of the PD-1 molecule. When PD-1 binds to PD-IL, the relay protein dissociates from PD-1 and starts functioning as a transcription factor. The figure below is an IHC experiment using T cells that have been exposed to PD-1L; where the primary antibody is "anti-RP". Which cells have been treated with PD-IL and which cells represent "control", untreated cells? (A or B?). Please explain your logic briefly. B
Expert Answer:
Answer rating: 100% (QA)
Question For question a the answer is P2 since P2 only expresses t... View the full answer
Related Book For
Statistics for Business Decision Making and Analysis
ISBN: 978-0321890269
2nd edition
Authors: Robert Stine, Dean Foster
Posted Date:
Students also viewed these business communication questions
-
A group of students on spring break manages to reach a deserted island in their wrecked sailboat. They splash ashore with fuel, a European gasoline-powered 240-V generator, a box of North American...
-
A group of students held their breath as long as possible and recorded the times in seconds. The times went from a low of 25 seconds to a high of 90 seconds, as you can see in the stemplot. Suggest...
-
A group of students in a probability course is skeptical about Geometric random variables, so one day; they all bring a die to class. Each of the 40 students rolls her/his die repeatedly. Each...
-
Suzanne acquired the following ordinary shares in Quarine plc: She made no further acquisitions and the shares were valued at 3.20 each on 31 March 1982. On 24 July 2020, Suzanne sold 1,200 shares...
-
You have the same information as in question 4 above, except that the pricing is for a European option. What is different?
-
Identify the major areas of social responsibility for international business.
-
The coefficient of determination R2 measures the percentage of variation in the outcome that is explained by the model. In Exercises 9 and 10, determine whether the statement is true or false. If the...
-
Aaron, a resident of Minnesota, has been a driver for Green Delivery Service for the past six years. For this purpose, he leases a truck from Green, and his compensation is based on a percentage of...
-
You are engaged in a large project that requires complex coordination between many departments in your organisation. You have almost completed the planning phase and are looking for sign-off of the...
-
Using the following information on Rockboro Case please answer the following Question: What are the problems here, and what do you recommend and what are the implications of different payout levels...
-
Montalbo Design Inc. sells a variety of porcelain products including porcelain sinks. In December 31, the company had 1,000 sinks in inventory. The company's policy is to maintain a sink inventory...
-
Question 2 A long municipal discharge pipe can be modelled as a source of strength m. The pipe is placed at a distance b from the bottom of a deep containment tank as shown in Figure 2. The city...
-
Put the following the steps of the accounting cycle in the correct order Prepare a post - closing trial balance. Prepare financial statements ( Income Statement, Statement of Retained Earnings,...
-
A solid sphere of diameter A is dropped in vacuum from a variable height H . At the bottom, you have a photosensor that measures the time interval ( DT ) between the bottom and top of the sphere...
-
A distance that a cart traveled was measured to be 4 . 8 1 m with an uncertainty of 0 . 2 1 4 m . The proper way to write this measurement with its uncertainty would be: Question 1 0 options: ( 5 \...
-
PART A: The total amount of expense arising from these options to be recorded for the year ended December 31, YR08 is: PART B: . The total amount of expense arising from these options to be recorded...
-
(CPA) Purvis Company manufactures a product that has a variable cost of $50 per unit. Fixed costs total $1,000,000 and are allocated on the basis of the number of units produced. Selling price is...
-
The test statistic in the NeymanPearson Lemma and the likelihood ratio test statistic K are intimately related. Consider testing H 0 : = 0 versus H a : = a , and let * denote the test statistic...
-
These two pie charts show the origin of cars bought by customers who traded in domestic and Asian models. For example, among those trading in a car produced by a domestic manufacturer, 29% purchased...
-
To boost interest in its big sale, a retailer offers special scratch-off coupons. When the shopper makes a purchase, the clerk scratches off the covering to reveal the amount of the discount. The...
-
A firm that operates a large, direct-to-consumer sales force would like to build a system to monitor the progress of new agents. The goal is to identify superstar agents as rapidly as possible, offer...
-
The equations of motion of a two-degree-of-freedom system are given by where \(F_{1}(t)\) denotes a rectangular pulse of magnitude 5 acting over \(0 \leq t \leq 2\). Find the solution of the...
-
Find the response of a simple pendulum numerically by solving the linearized equation: \[\ddot{\theta}+\frac{g}{l} \theta=0\] with \(\frac{g}{l}=0.01\) and plot the response, \(\theta(t)\), for \(0...
-
Find the response of a simple pendulum numerically by solving the exact equation: \[\ddot{\theta}+\frac{g}{l} \sin \theta=0\] with \(\frac{g}{l}=0.01\) and plot the response, \(\theta(t)\), for \(0...
Study smarter with the SolutionInn App